The team, led by Marian Marchiori of the University of Southern Denmark, conducted an umbrella review, a systematic search of reviews, to catalogue the ways accelerometer data are condensed into meaningful numbers. Searching Scopus and Web of Science in February 2025, they screened 324 reviews and ultimately included 93, published between 2012 and 2024. Those reviews collectively covered 5,667 original studies, of which 4,669 relied on accelerometers. From this enormous body of work, the researchers identified 134 distinct output metrics used to describe human movement behaviour, a striking illustration of how fragmented measurement practice has become in a field that ostensibly studies the same handful of behaviours.

The most familiar metrics dominated the landscape. Step counts appeared in 67 of the 93 reviews, making it the single most cited measure, followed closely by time spent in moderate-to-vigorous physical activity, or MVPA, which appeared in 65 reviews. Time in light physical activity, raw accelerometer counts, total sedentary time and total physical activity time rounded out the top tier. But beyond these household names, the long tail of metrics reveals genuine complexity: measures of bout duration, fragmentation, circadian patterns, intensity gradients and machine-learned activity types all jostle for space in the literature, each capturing a different facet of how people move through their days.

To bring order to this sprawl, the researchers performed an adapted thematic analysis, grouping the 134 metrics into five conceptual themes: relative measures, frequency, absolute time, point in time, and summary, pattern or derived measures. These categories map neatly onto the questions researchers actually ask of their data. Frequency metrics answer the question of how often a behaviour occurs, such as how many times a day someone stands up from sitting. Absolute time metrics answer how long a behaviour lasts. Relative measures capture what proportion of the day is spent in each behaviour, while point-in-time metrics pinpoint when behaviours begin and end. Summary and derived measures, such as raw acceleration aggregates like ENMO or MIMS units, describe the overall quantity and intensity of movement.

The visualisation side of the story proved even more revealing. When the researchers attempted a systematic search for studies on visualising accelerometer metrics, they came up essentially empty-handed; the literature simply does not treat visualisation as a topic worthy of systematic investigation in its own right. Falling back on non-systematic web searches and consultations with the generative AI tool Microsoft Copilot, they identified 28 different types of visualisations applicable to the metrics they had catalogued. Yet in practice, researchers overwhelmingly rely on just three: bar charts, line graphs and pie charts, typically chosen without any explicit rationale for why one format suits a particular metric or message better than another.

This gap matters more than it might seem. Data visualisation is not a cosmetic afterthought; it shapes how findings are understood, and the optimal chart for one audience may fail another entirely. A policy maker glancing at a report, a clinician interpreting a patient’s activity profile and a researcher scrutinising statistical patterns bring different expectations and different levels of statistical literacy. Terms like MVPA, second nature to exercise scientists, mean little to the general public. The authors point out that presenting only point estimates without any indication of variability can actively mislead audiences without statistical training, and that the same data rendered in different visual forms can elicit competing interpretations.

To address the problem, the team built a conceptual framework grounded in the sender-receiver model of communication, borrowed from the philosophy of language. In this framing, the researcher is the sender, the target audience is the receiver, and the visualisation is the coding strategy that transforms raw data into a transmissible message. The data themselves constitute the message, while journals and conference presentations serve as the channel. Noise, in this model, is anything that obscures the intended meaning, from cluttered graphics to jargon-heavy labels. The framework walks researchers through a sequence of decision points: identify whether the underlying data are unclassified, producing intensity or quantity metrics, or classified, producing behaviour types and intensity levels; determine which research question the metric answers, whether how much, how long, how often, when, or what proportion; and only then select a visualisation suited to that category and context.

The framework is deliberately non-prescriptive. Rather than dictating that a given metric must always be drawn a certain way, it organises options and illustrates pathways. One worked example contrasts a pie chart showing daily proportions of movement behaviours with a stacked bar plot, which preserves information about day-to-day variation and temporal patterns while still allowing comparison between averages and individual days. Another contrasts a simple bar plot counting activity bouts with an event plot, which additionally reveals the duration and timing of each individual bout. In both cases, the less conventional option can convey substantially more insight, depending on what the researcher actually wants to communicate.

The study’s authors are candid about its limitations. No review protocol was pre-registered, the search captured reviews published only up to 2024, and the exploratory visualisation searches, by necessity, were not systematic. The framework also lacks empirical validation: nobody yet knows how different audiences actually perceive the visualisations it recommends. The team calls for future work involving co-design with end users, comprehension testing and iterative refinement, ideally extending the framework to offer audience-specific guidance. They also note that the field would benefit enormously from a common taxonomy of movement behaviour metrics and from harmonised accelerometer data processing, initiatives already underway in consortia such as ProPASS, which would make visualisations more comparable across studies.

Nevertheless, the significance of the work lies in reframing visualisation as a communication problem rather than a technical one. With the World Health Organization reporting that insufficient physical activity has been rising globally since 2000, with stark disparities by sex, age and geography, the stakes of clear communication are high. Physical activity guidelines can only change behaviour if their messages land, and charts are often the first and most persuasive point of contact between research and the public. By cataloguing 134 metrics, mapping 28 visualisation types onto them, and embedding the whole exercise in a theory of communication, the LABDA team has given movement scientists something the field has never had: a systematic starting point for deciding not just what to measure, but how to show it.

Subject of Research: Visualisation of accelerometer-based 24/7 human movement behaviour metrics

Article Title: Visualising accelerometer-based 24/7 human movement behaviour data: an umbrella review and framework development from the LABDA project

Article References: Visualising accelerometer-based 24/7 human movement behaviour data: an umbrella review and framework development from the LABDA project. (n.d.). https://doi.org/10.1186/s44167-025-00088-6

Image Credits: AI Generated

DOI: 10.1186/s44167-025-00088-6

Keywords: accelerometers, physical activity, sedentary behaviour, sleep, data visualisation, wearables, 24/7 movement behaviours, MVPA, step counts, umbrella review, LABDA project, science communication

The trial enrolled 355 community-dwelling adults aged 65 and older in Kashiwa, Japan, all of whom showed at least one marker of physical vulnerability: low body-mass index for their age, pre-frailty or frailty on a standard questionnaire, or sarcopenia-related decline such as weak grip strength, slow gait speed, or reduced skeletal muscle mass. Roughly half of the participants scored below the cut-off for suspected mild cognitive impairment on the Montreal Cognitive Assessment, or MoCA, at baseline. Participants were randomly assigned in equal numbers to an automated intervention or to an assessment-only control group that received no advice, education, or prompting of any kind.

The intervention itself was strikingly lean on human input. Participants in the active arm wore a Fitbit Charge 5 continuously for six months, including during sleep. After an initial 28-day baseline window with no prompts, the system began issuing text-message alerts generated entirely from each participant’s own averaged lifelog data, with no counsellor, coach, or clinician shaping the content. Human contact was limited to a group orientation, device setup, and technical support by telephone. The prompts were purely threshold-based goal setting: daily step targets climbed in steps from 3,000 to 8,000; weekly exercise targets rose from 45 to 150 minutes, matching the World Health Organization recommendation for moderate-intensity activity; sleep targets aimed for a six-to-nine-hour nightly band; and an optional nutrition component, tracked through a food-logging application, encouraged participants to raise the share of energy they obtained from protein to 15 to 20 percent.

What makes INSPIOR distinctive is that no previous randomised trial of a multidomain lifestyle intervention has generated and delivered its behavioural content automatically from objective daily data while also measuring cognition as a primary outcome. Earlier landmark efforts, including the Finnish FINGER trial and more recent programmes in the United States, Australia, Japan, and elsewhere, depended on intensive face-to-face coaching or human-led sessions, which makes broad implementation expensive and difficult. A Cochrane review concluded that multidomain interventions confer small and inconsistent cognitive benefits, and the evidence base for the nutritional component of such programmes has been particularly weak, with a randomised trial of the MIND diet showing no advantage for global cognition over an active control diet.

On the trial’s three co-primary outcomes, only one showed a between-group difference. Global cognition, measured by the Japanese version of the MoCA, favoured the intervention by an adjusted 0.58 points on the 30-point scale, a difference that reached nominal statistical significance in the intention-to-treat analysis. However, because the trial registered three co-primary outcomes without a pre-specified hierarchy or multiplicity strategy, the authors also analysed all three jointly with Holm adjustment, and under that stricter accounting the MoCA result was no longer statistically significant. Executive function, measured by the Trail Making Test, showed no between-group difference at all, and skeletal muscle mass was essentially unchanged, with an adjusted difference of just 0.01 kilograms per square metre.

The behavioural data told a clearer story. In per-protocol analyses of the continuously recorded device logs, intervention participants moved an average of 696 more steps per day, accumulated 6.6 more minutes of active time per day, and slept 11.6 minutes longer per night than controls, relative to their own baselines. Notably, for steps and sleep both groups declined over the six months, and the difference reflects a smaller decline in the intervention group rather than an absolute improvement. Protein intake rose by nearly 8 grams per day in participants who opted into the dietary component, and a modest difference in the frailty index also favoured the intervention. Yet the authors caution that only the intervention group wore the device continuously, so some of these behavioural differences may reflect reactivity to being measured rather than a true effect of the prompts.

In an exploratory model entering changes in exercise, sleep, and protein intake simultaneously, only the change in exercise was associated with the change in MoCA score, with a standardised coefficient of 0.24. The investigators are careful to insist that this association cannot be read as proof of a mechanism. The model is observational, the behavioural measures were recorded under different conditions in the two groups, and the activity, sleep, and nutrition components were delivered together, making it impossible to attribute any cognitive change to a single ingredient. A post-hoc responder analysis found that 60 percent of intervention participants improved by at least one MoCA point, compared with 41 percent of controls, but the thresholds used were never pre-specified or established as clinically important.

The trial also carries methodological caveats that the authors lay out with unusual transparency. It was open-label, and the staff who assessed outcomes at six months had also set up devices and managed the study, so they could often recognise participants and infer their group. Allocation concealment was not implemented as a separate procedure, and the authors note that a 0.58-point difference is small enough that even modest bias could matter. A procedural problem with the baseline Trail Making Test, which was administered under a non-standard procedure and re-administered after allocation, means the executive-function estimates must be treated as non-confirmatory. The absence of corroboration on a second cognitive instrument, they write, weakens the case that the MoCA difference reflects a broad cognitive benefit.

What, then, does a 0.58-point shift on the MoCA actually mean? No universally accepted minimal clinically important difference exists for the instrument, but a distribution-based estimate puts it at 1.0 point, a figure compatible with the upper bound of the trial’s confidence interval but not with the point estimate itself. The authors therefore read the finding not as a clinically meaningful improvement for any individual but as a small shift in the population distribution of cognitive scores, of uncertain significance. They note that even a one-point difference on a 30-point screening instrument has been associated with a higher rate of recorded dementia diagnosis in observational cohorts, which is precisely why larger trials are warranted rather than why the result should be celebrated.

The broader implication is about delivery rather than effect size. INSPIOR demonstrates that a multidomain prevention programme can run at community scale with human contact limited to setup and troubleshooting, reaching a risk-enriched population that previous coaching-heavy trials struggled to serve efficiently. No serious adverse events related to the device, the dietary application, or the protein-balanced food supplied to some participants were reported, and mild skin irritation and the burden of daily dietary recording were the only intervention-related complaints. The authors conclude that wearable-centric, automated programmes may offer a scalable route to supporting healthy ageing, but that this trial does not establish that they prevent cognitive decline. Larger, longer, multicentre trials with masked outcome assessment are now needed to determine whether the small cognitive signal observed in Kashiwa is durable, clinically meaningful, and attributable to any particular component of the automated package.

Subject of Research: A wearable-based automated multidomain lifestyle intervention for cognitive and physical function in older adults at risk of decline

Article Title: Effect of a wearable-based individualised multidomain lifestyle intervention on cognitive and physical function in older adults at risk of decline (INSPIOR): a single-centre, open-label, randomised controlled trial

Article References: Sakurai, K., Tanaka, R., Ledsam, J., Shiraishi, I., Kasahara, H., Anzai, S., Watanabe, M., Funakawa, M., Shimada, S., Goto, T., Kawabata, R., Murasakino, K., Kawaura, T., Inamura, N., Kaneta, K., Kobayashi, S., Nomura, T., Karasawa, N., Matsumoto, T., … Hisatsune, T. (2026). Effect of a wearable-based individualised multidomain lifestyle intervention on cognitive and physical function in older adults at risk of decline (INSPIOR): a single-centre, open-label, randomised controlled trial. eClinicalMedicine, 100, Article 104212. https://doi.org/10.1016/j.eclinm.2026.104212

Image Credits: AI Generated

DOI: 10.1016/j.eclinm.2026.104212

Keywords: wearables, cognitive decline, dementia prevention, multidomain intervention, randomised controlled trial, older adults, physical activity, sleep, nutrition, MoCA, digital health, frailty

The study’s focus is heart rate variability, or HRV, the beat-to-beat fluctuation in the intervals between consecutive heartbeats. Far from being a sign of irregularity, HRV is a marker of physiological flexibility. A heart governed by a well-tuned autonomic nervous system does not tick like a metronome; it constantly adjusts, speeding slightly with each inhalation and slowing with each exhalation, responding to posture, stress, temperature, and a thousand other inputs. Higher HRV is generally interpreted as evidence of a healthy balance between the sympathetic branch of the autonomic nervous system, which mobilizes the body for action, and the parasympathetic branch, which promotes rest and recovery. Lower HRV, by contrast, has been repeatedly linked in clinical literature to stress, inflammation, and elevated risk of cardiovascular events.

Why would noise matter to this delicate balance? The biological rationale rests on the idea that unwanted sound acts as a stressor even during sleep, when conscious annoyance is absent. Noise exposure has been associated in prior research with activation of the hypothalamic-pituitary-adrenal axis, release of stress hormones such as cortisol and catecholamines, endothelial dysfunction, oxidative stress, and low-grade vascular inflammation. Epidemiological studies have connected chronic exposure to traffic and aircraft noise with hypertension, ischemic heart disease, and stroke, prompting the World Health Organization to rank environmental noise among the leading environmental burdens of disease in Europe. What has been harder to establish is how noise relates to the fine-grained, moment-to-moment autonomic regulation that HRV captures, particularly outside the laboratory and across ordinary life.

This is precisely the gap the Apple Hearing Study analysis was designed to address. The parent study, launched through the ResearchKit framework within the Apple Research app, enrolled hundreds of thousands of iPhone and Apple Watch users across the United States who consented to share data on their noise environments and hearing health. Participants’ devices passively estimate environmental sound levels, and the study also collects information about headphone listening habits through a dedicated questionnaire and volume-monitoring features. By pairing these exposure measures with heart rate variability data recorded by the same wrist-worn devices, the researchers were able to construct an unusually rich, longitudinal picture of how acoustic environments and cardiac autonomic state vary together in daily life.

The methodological strengths of this design deserve emphasis. Traditional noise epidemiology has often relied on modelled exposure, estimating the sound levels at participants’ homes from traffic maps or airport flight paths. Such approaches capture chronic spatial exposure but miss the enormous person-to-person variation in where people actually go and what they actually hear. Consumer wearables invert that paradigm: they measure exposure at the individual level, in near real time, across workdays and weekends, commutes and quiet evenings. Similarly, HRV has historically been assessed in clinical settings with electrocardiography over short intervals, but the Apple Watch computes heart rate variability continuously from photoplethysmographic signals, allowing researchers to examine autonomic dynamics across weeks and months rather than minutes. The result is a dataset with a resolution and ecological validity that laboratory studies cannot match.

That resolution comes with challenges, and the study’s authors confront them directly. Consumer-grade sensors introduce measurement error: optical heart rate recordings can be degraded by motion, skin tone, watch fit, and device generation, and microphone-based sound level estimates reflect the acoustic environment around the watch rather than the dose reaching the ear, particularly for headphone listening. Confounding is a further concern, since people exposed to louder environments may also differ in socioeconomic status, occupation, physical activity, sleep patterns, smoking, and underlying health, any of which could independently influence HRV. Analyses of this kind therefore depend heavily on statistical adjustment, stratification, and sensitivity testing to separate a plausible noise effect from the many correlated features of modern urban life.

The distinction between environmental noise and headphone noise is one of the study’s most interesting framing choices. Environmental noise, dominated by road traffic, aircraft, and neighborhood soundscapes, is largely involuntary; people cannot simply switch it off, and exposure accumulates over decades of residence and employment. Headphone noise, by contrast, is self-administered and controllable, yet it can reach the ear at levels comparable to or exceeding hazardous environmental exposures, particularly among young listeners who wear earbuds for hours each day. Public health campaigns have long warned about headphone volume as a risk to hearing, but its potential role as a systemic stressor affecting autonomic function has received far less attention. By treating both exposure types within a single analytical framework, the study invites a broader view of noise as a modifiable cardiovascular risk factor, not merely an occupational hazard for the inner ear.

The implications of such work extend in several directions. For researchers, the findings help validate consumer wearables as instruments for environmental health science, demonstrating that data collected passively by millions of devices can illuminate physiological relationships previously studied only in small, controlled cohorts. For clinicians, an association between noise and reduced heart rate variability would add a mechanistic link to the established epidemiological chain connecting noise exposure with hypertension and cardiovascular disease, suggesting that autonomic dysregulation may be one pathway through which sound becomes pathology. For the public, the message is potentially empowering: unlike many environmental exposures, noise from personal audio devices is directly controllable, and simple behaviors such as lowering listening volume, taking listening breaks, and favoring noise-cancelling or well-sealing headphones at lower settings could reduce both auditory and possibly systemic risk.

Caution remains warranted. Observational associations, even in very large cohorts, cannot by themselves prove causation, and residual confounding is notoriously difficult to eliminate in app-based research, where participants skew toward younger, healthier, and more technologically engaged populations than the general public. Reverse causation is also conceivable, since people with certain health conditions may spend more time indoors in quieter environments or use headphones differently. The authors’ contribution lies less in delivering a final verdict than in establishing a scalable template: repeated, individual-level measurement of both exposure and outcome, analyzed with the statistical tools of modern epidemiology, and grounded in an explicit biological model of how acoustic stress translates into autonomic change.

What the study ultimately underscores is that the soundscape of modern life is not neutral. From the rumble of freight trucks on the morning commute to the podcast streamed directly into the ear canal for hours at a time, acoustic energy is a constant physiological input, and the cardiovascular system appears to register it. As wearable technology continues to blur the boundary between consumer product and medical instrument, studies of this kind point toward a future in which the health effects of our acoustic environments can be monitored continuously, understood at the level of individuals, and, perhaps, mitigated before they accumulate into disease. In the meantime, the research adds a quiet argument for turning the volume down, both outside and inside our headphones.

Subject of Research: Associations between environmental and headphone noise exposure and heart rate variability in the Apple Hearing Study cohort

Article Title: Association between environmental and headphone noise and heart rate variability: observations from Apple Hearing Study cohort

Article References: Zhang, X., Park, S. K., Smith, L. M., & Neitzel, R. L. (2026). Association between environmental and headphone noise and heart rate variability: observations from Apple Hearing Study cohort. Journal of Exposure Science & Environmental Epidemiology. https://doi.org/10.1038/s41370-026-00970-8

Image Credits: AI Generated

DOI: 10.1038/s41370-026-00970-8

Keywords: noise exposure, heart rate variability, Apple Hearing Study, wearables, environmental health, headphone listening, autonomic nervous system, cardiovascular risk, epidemiology, digital health, Association, between